JP2022522803A5 - - Google Patents

Info

Publication number
JP2022522803A5
JP2022522803A5 JP2021551880A JP2021551880A JP2022522803A5 JP 2022522803 A5 JP2022522803 A5 JP 2022522803A5 JP 2021551880 A JP2021551880 A JP 2021551880A JP 2021551880 A JP2021551880 A JP 2021551880A JP 2022522803 A5 JP2022522803 A5 JP 2022522803A5
Authority
JP
Japan
Prior art keywords
cyfra21
flt3l
areg
colorectal cancer
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021551880A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022522803A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/055277 external-priority patent/WO2020178172A1/en
Publication of JP2022522803A publication Critical patent/JP2022522803A/ja
Publication of JP2022522803A5 publication Critical patent/JP2022522803A5/ja
Priority to JP2024224464A priority Critical patent/JP2025038186A/ja
Pending legal-status Critical Current

Links

JP2021551880A 2019-03-01 2020-02-28 結腸直腸癌及び/又はその前癌段階の診断用タンパク質シグネチャー Pending JP2022522803A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024224464A JP2025038186A (ja) 2019-03-01 2024-12-19 結腸直腸癌及び/又はその前癌段階の診断用タンパク質シグネチャー

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP19382157.6 2019-03-01
EP19382157 2019-03-01
EP19382156 2019-03-01
EP19382156.8 2019-03-01
PCT/EP2020/055277 WO2020178172A1 (en) 2019-03-01 2020-02-28 Protein signature for the diagnosis of colorectal cancer and/or pre-cancerous stage thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024224464A Division JP2025038186A (ja) 2019-03-01 2024-12-19 結腸直腸癌及び/又はその前癌段階の診断用タンパク質シグネチャー

Publications (2)

Publication Number Publication Date
JP2022522803A JP2022522803A (ja) 2022-04-20
JP2022522803A5 true JP2022522803A5 (https=) 2023-03-07

Family

ID=69631636

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021551880A Pending JP2022522803A (ja) 2019-03-01 2020-02-28 結腸直腸癌及び/又はその前癌段階の診断用タンパク質シグネチャー
JP2024224464A Pending JP2025038186A (ja) 2019-03-01 2024-12-19 結腸直腸癌及び/又はその前癌段階の診断用タンパク質シグネチャー

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024224464A Pending JP2025038186A (ja) 2019-03-01 2024-12-19 結腸直腸癌及び/又はその前癌段階の診断用タンパク質シグネチャー

Country Status (10)

Country Link
US (1) US20220276249A1 (https=)
EP (1) EP3931571B1 (https=)
JP (2) JP2022522803A (https=)
KR (1) KR102769007B1 (https=)
CN (1) CN113785199B (https=)
AU (1) AU2020230963B2 (https=)
CA (1) CA3131729A1 (https=)
ES (1) ES2952139T3 (https=)
MX (1) MX2021010451A (https=)
WO (1) WO2020178172A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2952139T3 (es) * 2019-03-01 2023-10-27 Advanced Marker Discovery S L Firma proteica para el diagnóstico de cáncer colorrectal y/o etapa precancerosa del mismo
WO2021185982A1 (en) * 2020-03-19 2021-09-23 Advanced Marker Discovery S.l. Protein signature for screening general population for colorectal cancer and/or pre-cancerous stage thereof
CA3202255A1 (en) 2020-12-21 2022-06-30 Hayley WARSINSKE Markers for the early detection of colon cell proliferative disorders
KR102900859B1 (ko) * 2021-12-31 2025-12-17 주식회사 이노제닉스 대장암 및 대장 용종 또는 진행 선종의 선별 방법 및 그 응용

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005014386D1 (de) * 2004-12-23 2009-06-18 Roche Diagnostics Gmbh Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome
CN101896817A (zh) * 2007-12-10 2010-11-24 霍夫曼-拉罗奇有限公司 用于结直肠癌的标记物组
CN103140760B (zh) * 2010-07-14 2016-01-27 联邦科学与工业研究组织 结肠直肠癌的诊断
US20140220006A1 (en) * 2013-02-01 2014-08-07 Meso Scale Technologies, Llc Lung cancer biomarkers
US20160291025A1 (en) * 2013-09-18 2016-10-06 Adelaide Research & Innovation Pty Ltd Autoantibody biomarkers of ovarian cancer
JP6339399B2 (ja) * 2014-03-28 2018-06-06 学校法人北里研究所 卵巣明細胞腺癌細胞の検出方法、卵巣明細胞腺癌診断薬、卵巣明細胞腺癌診断用プライマー、卵巣明細胞腺癌診断用キット、及び卵巣明細胞腺癌診断用プローブ
EP3073268A1 (en) * 2015-03-27 2016-09-28 Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts Biomarker panel for diagnosing cancer
JP2018136122A (ja) * 2015-05-29 2018-08-30 国立研究開発法人国立がん研究センター 膵がんを診断するための血漿バイオマーカーパネル
US20180160885A1 (en) * 2016-12-13 2018-06-14 Prosper Abitbol Endoscopy based medical devices, methods, and innovations
KR102018205B1 (ko) * 2017-07-24 2019-09-05 (주) 바이오인프라생명과학 대장암 진단용 조성물 및 상기 조성물을 이용한 대장암 진단 방법
US10968583B2 (en) * 2017-07-26 2021-04-06 David E. Lambert Reflective road marker
ES2952139T3 (es) * 2019-03-01 2023-10-27 Advanced Marker Discovery S L Firma proteica para el diagnóstico de cáncer colorrectal y/o etapa precancerosa del mismo
WO2021185982A1 (en) * 2020-03-19 2021-09-23 Advanced Marker Discovery S.l. Protein signature for screening general population for colorectal cancer and/or pre-cancerous stage thereof

Similar Documents

Publication Publication Date Title
JP2022522803A5 (https=)
BR112014016158A8 (pt) medições exatas de analito para tira de teste eletroquímica com base na(s) característica(s) física(s) detectada(s) da amostra contendo o analito
ATE550642T1 (de) Verfahren zur messung von 1,5-anhydroglucitol in vollblut
WO2015100459A3 (en) Biomarker profiles for predicting outcomes of cancer therapy with erbb3 inhibitors and/or chemotherapies
Sindhu et al. Saliva: a cutting edge in diagnostic procedures
JP2018504609A5 (https=)
TW200745543A (en) System and methods for providing corrected analyte concentration measurements
JP2022533033A5 (https=)
ATE539675T1 (de) System und verfahren zur bestimmung einer analytenkonzentration mit einer hämatokrit- korrektur
RU2019143570A (ru) Диагностика периодонтита на основании hgf и mmp-8 в слюне
Muñoz-Lucas et al. Influence of chronic obstructive pulmonary disease on volatile organic compounds in patients with non-small cell lung cancer
CN105954527B (zh) 临床样本自动分析仪器
AR071034A1 (es) Uso de la catepsina c en el diagnostico de susceptibilidad al dolor y para el tratamiento del dolor
JP2019510974A5 (https=)
EP2549270A3 (en) Biosensor desiccant system having enhanced measurement performance
JP6800470B2 (ja) miRNAをマーカーとする歯周炎検査キット、及び検査方法
ATE476527T1 (de) Quantifizierungsverfahren für die vegf isoformen einer biologischen probe
RU2021128559A (ru) Белковая сигнатура для диагностики колоректального рака и/или его предраковой стадии
JP4825828B2 (ja) 銀染色を用いる電気泳動法により腎疾患等の病態を判定する方法
JP2025520600A5 (https=)
WO2022197659A2 (en) Fluorescence detection of circulating cell free dna including within extracellualr vesicles in biospecimens and liquid biopsies
ATE530906T1 (de) Verfahren zur unterscheidung zwischen einen gemeinsamen analyten enthaltenden blut- und kontrollösungen
WO2021159128A3 (en) Methods and kit for detection of analytes
ATE466285T1 (de) Diagnose von leberzirrhose mittels eines für menschliches protoonkogenes protein spezifischen antikörpers
JP2018181352A5 (https=)